{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:07:34Z","timestamp":1763507254166,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08557","23K08535","23H04937","24K02195"],"award-info":[{"award-number":["23K08557","23K08535","23H04937","24K02195"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Platform Project for Supporting Drug Discovery and Life Science Research","award":["JP24ama121018"],"award-info":[{"award-number":["JP24ama121018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurological disorders, such as stroke and traumatic brain injury are the most significant global health challenges, leading to long-term physical and cognitive impairments. Cell transplantation therapy holds substantial promise for facilitating recovery, with numerous clinical trials currently underway. Intracerebral stem cell infusion offers the advantage of directly delivering a sufficient number of stem cells to the targeted area. Both our team and other researchers have observed a notable phenomenon following intracerebral stem cell therapy in clinical trials, wherein transient edema, as detected by Fluid Attenuated Inversion Recovery (FLAIR) magnetic resonance (MR) imaging, can be monitored between one and two weeks post-transplantation, with a subsequent resolution occurring approximately one month later. Notably, patient recovery appears to accelerate during the period of elevated FLAIR signals. However, the precise mechanisms underlying this distinctive phenomenon remain poorly understood. Therefore, this reverse translational research employs proteomics and histological analysis to investigate the mechanisms driving this phenomenon, thereby enhancing our understanding of stem cell therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bone marrow-derived mesenchymal stem cells (BMSCs) were isolated from Sprague-Dawley (SD) rats, with passage 3 cells utilized for subsequent experiments. A total of one million cells, suspended in 10 \u00b5L of phosphate-buffered saline, were intracerebrally transplanted into the striatum of SD rats. Serial magnetic resonance imaging (FLAIR) scans were performed up to three weeks post-transplantation. Brain tissues were collected from the pre-signal (1 week post-transplantation), signal (2 weeks post-transplantation), and post-signal (3 weeks post-transplantation) groups for proteomic analysis, network analysis, and immunofluorescence imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Consistent with clinical trials, transient FLAIR hyperintense signals were not detected until approximately two weeks post-intracranial stem cell therapy. These signals emerged around week two and diminished by week three. Proteomic analysis of brain specimens from the pre-signal and signal groups identified 231 differentially expressed proteins, which were primarily involved in vesicle-mediated transport, synaptic remodeling, and cellular communication. Glial fibrillary acidic protein (GFAP), Aquaporin-4 (AQP4), and Apolipoprotein E (APOE) were identified as key hub proteins. Immunofluorescence studies further confirmed that expression levels of GFAP, AQP4, and APOE increased around two weeks post-transplantation and significantly decreased by week three, coinciding with the resolution of the FLAIR signal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that the transient FLAIR hyperintensity observed following intracerebral stem cell therapy is primarily attributed to transient glial cell activation, resulting in increased AQP4 expression and transient brain water influx. Additional mechanisms, including vesicle-mediated transport, secretion, synaptic activity, and lipid signaling, also contribute to the transient FLAIR hyperintensity signals and may play a role in the manifestation of clinical symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04757-w","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:59:44Z","timestamp":1763463584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reverse translational research of transient magnetic resonance imaging hyperintensity following intracranial stem cell therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Yi","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-8380","authenticated-orcid":false,"given":"Masahito","family":"Kawabori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khin Khin","family":"Tha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"8","key":"4757_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke Statistics-2022 update: A report from the American heart association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"issue":"2","key":"4757_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0003-9993(97)90252-5","volume":"78","author":"DX Cifu","year":"1997","unstructured":"Cifu DX, Keyser-Marcus L, Lopez E, Wehman P, Kreutzer JS, Englander J, et al. Acute predictors of successful return to work 1 year after traumatic brain injury: a multicenter analysis. Arch Phys Med Rehabil. 1997;78(2):125\u201331.","journal-title":"Arch Phys Med Rehabil"},{"key":"4757_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms21197380","volume":"21","author":"M Kawabori","year":"2020","unstructured":"Kawabori M, Shichinohe H, Kuroda S, Houkin K. Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci. 2020;21:19.","journal-title":"Int J Mol Sci"},{"key":"4757_CR4","doi-asserted-by":"publisher","first-page":"963689723115815","DOI":"10.1177\/09636897231158153","volume":"32","author":"S Takamiya","year":"2023","unstructured":"Takamiya S, Kawabori M, Fujimura M. Stem cell therapies for intracerebral hemorrhage: review of preclinical and clinical studies. Cell Transpl. 2023;32:9636897231158153.","journal-title":"Cell Transpl"},{"key":"4757_CR5","doi-asserted-by":"crossref","unstructured":"Yamazaki K, Kawabori M, Seki T, Houkin K. Clinical trials of stem cell treatment for spinal cord injury. Int J Mol Sci. 2020;21(11).","DOI":"10.3390\/ijms21113994"},{"issue":"12","key":"4757_CR6","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1080\/03007995.2022.2141482","volume":"38","author":"M Kawabori","year":"2022","unstructured":"Kawabori M, Chida D, Nejadnik B, Stonehouse AH, Okonkwo DO. Cell therapies for acute and chronic traumatic brain injury. Curr Med Res Opin. 2022;38(12):2183\u20139.","journal-title":"Curr Med Res Opin"},{"key":"4757_CR7","doi-asserted-by":"crossref","unstructured":"Kawabori M, Weintraub AH, Imai H, Zinkevych L, McAllister P, Steinberg GK et al. Cell therapy for chronic TBI: interim analysis of the randomized controlled STEMTRA trial. Neurology. 2021.","DOI":"10.1212\/WNL.0000000000011450"},{"key":"4757_CR8","doi-asserted-by":"crossref","unstructured":"Kawabori M, Kuroda S, Shichinohe H, Kahata K, Shiratori S, Ikeda S et al. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke. Med. 2024:432\u201344.","DOI":"10.1016\/j.medj.2024.02.009"},{"issue":"7","key":"4757_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, et al. Clinical outcomes of transplanted modified bone Marrow-Derived mesenchymal stem cells in stroke: A phase 1\/2a study. Stroke. 2016;47(7):1817\u201324.","journal-title":"Stroke"},{"issue":"10046","key":"4757_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","volume":"388","author":"D Kalladka","year":"2016","unstructured":"Kalladka D, Sinden J, Pollock K, Haig C, McLean J, Smith W, et al. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet. 2016;388(10046):787\u201396.","journal-title":"Lancet"},{"issue":"5","key":"4757_CR11","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3171\/2018.5.JNS173147","volume":"131","author":"GK Steinberg","year":"2019","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Kim AS, Johnson JN, et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow\u2013derived mesenchymal stem cells (SB623): a phase 1\/2a study. J Neurosurg JNS. 2019;131(5):1462\u201372.","journal-title":"J Neurosurg JNS"},{"issue":"3","key":"4757_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1440-1789.2011.01260.x","volume":"32","author":"M Kawabori","year":"2012","unstructured":"Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, Houkin K, et al. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology. 2012;32(3):217\u201326.","journal-title":"Neuropathology"},{"issue":"2","key":"4757_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1440-1789.2012.01335.x","volume":"33","author":"M Kawabori","year":"2013","unstructured":"Kawabori M, Kuroda S, Ito M, Shichinohe H, Houkin K, Kuge Y, et al. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology. 2013;33(2):140\u20138.","journal-title":"Neuropathology"},{"key":"4757_CR14","doi-asserted-by":"publisher","first-page":"9964877","DOI":"10.1155\/2021\/9964877","volume":"2021","author":"K Yamazaki","year":"2021","unstructured":"Yamazaki K, Kawabori M, Seki T, Takamiya S, Konno K, Watanabe M, et al. Mesenchymal stem cell sheet promotes functional recovery and palliates neuropathic pain in a subacute spinal cord injury model. Stem Cells Int. 2021;2021:9964877.","journal-title":"Stem Cells Int"},{"issue":"2","key":"4757_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1440-1789.2009.01050.x","volume":"30","author":"H Shichinohe","year":"2010","unstructured":"Shichinohe H, Kuroda S, Maruichi K, Osanai T, Sugiyama T, Chiba Y, et al. Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain? Neuropathology. 2010;30(2):113\u201322.","journal-title":"Neuropathology"},{"issue":"1","key":"4757_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2006.02.127","volume":"1087","author":"S Yamaguchi","year":"2006","unstructured":"Yamaguchi S, Kuroda S, Kobayashi H, Shichinohe H, Yano S, Hida K, et al. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC)--a preliminary study using microarray analysis. Brain Res. 2006;1087(1):15\u201327.","journal-title":"Brain Res"},{"issue":"3","key":"4757_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1440-1789.2003.00496.x","volume":"23","author":"J Lee","year":"2003","unstructured":"Lee J, Kuroda S, Shichinohe H, Ikeda J, Seki T, Hida K, et al. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology. 2003;23(3):169\u201380.","journal-title":"Neuropathology"},{"issue":"1","key":"4757_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes CS, Moggridge S, M\u00fcller T, Sorensen PH, Morin GB, Krijgsveld J. Single-pot, solid-phase-enhanced sample Preparation for proteomics experiments. Nat Protoc. 2019;14(1):68\u201385.","journal-title":"Nat Protoc"},{"issue":"4","key":"4757_CR19","doi-asserted-by":"publisher","first-page":"100745","DOI":"10.1016\/j.mcpro.2024.100745","volume":"23","author":"R Konno","year":"2024","unstructured":"Konno R, Ishikawa M, Nakajima D, Endo Y, Ohara O, Kawashima Y. Universal pretreatment development for Low-input proteomics using Lauryl maltose neopentyl glycol. Mol Cell Proteom. 2024;23(4):100745.","journal-title":"Mol Cell Proteom"},{"issue":"6","key":"4757_CR20","doi-asserted-by":"publisher","first-page":"104810","DOI":"10.1016\/j.jbc.2023.104810","volume":"299","author":"K Etoh","year":"2023","unstructured":"Etoh K, Nakao M. A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell\/tissue type-dependent action of Sulforaphane. J Biol Chem. 2023;299(6):104810.","journal-title":"J Biol Chem"},{"issue":"D1","key":"4757_CR21","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4757_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"8","key":"4757_CR23","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","volume":"35","author":"M Kawabori","year":"2015","unstructured":"Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, et al. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci. 2015;35(8):3384\u201396.","journal-title":"J Neurosci"},{"key":"4757_CR24","doi-asserted-by":"crossref","unstructured":"Morishima Y, Kawabori M, Yamazaki K, Takamiya S, Yamaguchi S, Nakahara Y, et al. Intravenous administration of mesenchymal stem cell-derived exosome alleviates spinal cord injury by regulating neutrophil extracellular trap formation through exosomal miR-125a-3p. Int J Mol Sci. 2024;25(4).","DOI":"10.3390\/ijms25042406"},{"issue":"7","key":"4757_CR25","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/mt.2009.104","volume":"17","author":"MM Daadi","year":"2009","unstructured":"Daadi MM, Li Z, Arac A, Grueter BA, Sofilos M, Malenka RC, et al. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther. 2009;17(7):1282\u201391.","journal-title":"Mol Ther"},{"issue":"1","key":"4757_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BST20120192","volume":"41","author":"G Camussi","year":"2013","unstructured":"Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013;41(1):283\u20137.","journal-title":"Biochem Soc Trans"},{"issue":"10","key":"4757_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR, Herz J, G\u00f6rgens A, Schlechter J, Ludwig A-K, Radtke S, et al. Extracellular vesicles improve Post-Stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131\u201343.","journal-title":"Stem Cells Transl Med"},{"key":"4757_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-pharmtox-010814-124630","volume":"55","author":"B Gy\u00f6rgy","year":"2015","unstructured":"Gy\u00f6rgy B, Hung ME, Breakefield XO, Leonard JN. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol. 2015;55:439\u201364.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"4757_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L, Ding J, Chen C, Wu Z-J, Liu B, Gao Y, et al. Exosome-Transmitted LncARSR promotes Sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29(5):653\u201368.","journal-title":"Cancer Cell"},{"issue":"10","key":"4757_CR30","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.2741\/4565","volume":"22","author":"GK Panigrahi","year":"2017","unstructured":"Panigrahi GK, Deep G. Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer. Front Biosci (Landmark Ed). 2017;22(10):1682\u201396.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"4757_CR31","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/foc.2007.22.5.5","volume":"22","author":"GA Rosenberg","year":"2007","unstructured":"Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus. 2007;22(5):E4.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"4757_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0271678X231209607","volume":"44","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhao J, Sha W-M, Zhang X-P, Mai J-Y, Bartlett PF, et al. Inhibition of EphA4 reduces vasogenic edema after experimental stroke in mice by protecting the blood-brain barrier integrity. J Cereb Blood Flow Metab. 2024;44(3):419\u201333.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4757_CR33","doi-asserted-by":"crossref","unstructured":"Kitchen P, Salman MM, Halsey AM, Clarke-Bland C, MacDonald JA, Ishida H, et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181(4).","DOI":"10.1016\/j.cell.2020.03.037"},{"key":"4757_CR34","doi-asserted-by":"crossref","unstructured":"Seblani M, Decherchi P, Brezun J-M. Edema after CNS trauma: A focus on spinal cord injury. Int J Mol Sci. 2023;24(8).","DOI":"10.3390\/ijms24087159"},{"key":"4757_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.neuroimage.2018.12.026","volume":"188","author":"Y Ohene","year":"2019","unstructured":"Ohene Y, Harrison IF, Nahavandi P, Ismail O, Bird EV, Ottersen OP, et al. Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study. NeuroImage. 2019;188:515\u201323.","journal-title":"NeuroImage"},{"issue":"4","key":"4757_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrd4226","volume":"13","author":"AS Verkman","year":"2014","unstructured":"Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov. 2014;13(4):259\u201377.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4757_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ymthe.2024.12.006","volume":"33","author":"B Klein","year":"2025","unstructured":"Klein B, Ciesielska A, Losada PM, Sato A, Shah-Morales S, Ford JB, et al. Modified human mesenchymal stromal\/stem cells restore cortical excitability after focal ischemic stroke in rats. Mol Ther. 2025;33(1):375\u2013400.","journal-title":"Mol Ther"},{"issue":"9","key":"4757_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV. Astrocyte reactivity: Subtypes, States, and functions in CNS innate immunity. Trends Immunol. 2020;41(9):758\u201370.","journal-title":"Trends Immunol"},{"issue":"6","key":"4757_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tem.2022.03.001","volume":"33","author":"X-Y Xiong","year":"2022","unstructured":"Xiong X-Y, Tang Y, Yang Q-W. Metabolic changes favor the activity and heterogeneity of reactive astrocytes. Trends Endocrinol Metab. 2022;33(6):390\u2013400.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"4757_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nn.4201","volume":"19","author":"N Bazargani","year":"2016","unstructured":"Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19(2):182\u20139.","journal-title":"Nat Neurosci"},{"issue":"4","key":"4757_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neuron.2020.12.008","volume":"109","author":"J Nagai","year":"2021","unstructured":"Nagai J, Yu X, Papouin T, Cheong E, Freeman MR, Monk KR, et al. Behaviorally consequential astrocytic regulation of neural circuits. Neuron. 2021;109(4):576\u201396.","journal-title":"Neuron"},{"key":"4757_CR42","doi-asserted-by":"publisher","first-page":"573256","DOI":"10.3389\/fimmu.2020.573256","volume":"11","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Rothhammer V. Protective functions of reactive astrocytes following central nervous system insult. Front Immunol. 2020;11:573256.","journal-title":"Front Immunol"},{"key":"4757_CR43","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.nbd.2019.104724","volume":"136","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, Rebeck GW. APOE in the normal brain. Neurobiol Dis. 2020;136:104724.","journal-title":"Neurobiol Dis"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04757-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:03:11Z","timestamp":1763506991000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4757"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04757-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal protocols were approved by the Animal Studies Ethics Committee of the Hokkaido University Graduate School of Medicine. Experimental title: basic experiment of stem cell treatment for brain disease. Approval number: 21\u20130123. Date of approval: 2022\/11\/14. All experimental procedures were conducted in accordance with the Institutional Guidelines for Animal Experimentation, the Guidelines for Proper Conduct of Animal Experiments issued by the Science Council of Japan, and the ARRIVE guidelines 2.0. All animals were housed in standard polypropylene cages (typically 2\u20133 rats per cage) under specific pathogen-free (SPF) conditions. The animal facility was maintained at a temperature of 22\u2009\u00b1\u20092\u00a0\u00b0C, with relative humidity of 50\u201360% and a 12-hour light\/dark cycle. Rats had ad libitum access to autoclaved food and water. Animals were monitored daily for health and welfare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to submit the manuscript, read and approved the final draft and take full responsibility of its content, including the accuracy of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"646"}}